[
  {
    "ts": null,
    "headline": "Barclays Lowers Humana (HUM) Price Target amid Questions on Margin Expansion Outlook",
    "summary": "Humana Inc. (NYSE:HUM) is included among the 14 Best GARP Stocks to Buy According to Analysts. On February 25, Barclays lowered its price recommendation on Humana Inc. (NYSE:HUM) to $176 from $245. The firm reiterated an Equal Weight rating on the shares. It said it is “incrementally cautious” about the company’s expectation that Individual Medicare […]",
    "url": "https://finnhub.io/api/news?id=078adb0ef9fb6590615a714b9bd093d664240eb66db147bff6bf729e65a2bd8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772171957,
      "headline": "Barclays Lowers Humana (HUM) Price Target amid Questions on Margin Expansion Outlook",
      "id": 139244700,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Humana Inc. (NYSE:HUM) is included among the 14 Best GARP Stocks to Buy According to Analysts. On February 25, Barclays lowered its price recommendation on Humana Inc. (NYSE:HUM) to $176 from $245. The firm reiterated an Equal Weight rating on the shares. It said it is “incrementally cautious” about the company’s expectation that Individual Medicare […]",
      "url": "https://finnhub.io/api/news?id=078adb0ef9fb6590615a714b9bd093d664240eb66db147bff6bf729e65a2bd8a"
    }
  }
]